Front Row Advisors LLC Stryker Corp Transaction History

Front Row Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$324.3 - $354.67 $3,891 - $4,256	-12 Reduced 19.35%	50 $17,000
Q1 2024 May 14, 2024	BUY	$293.94 - $358.71 $14,697 - $17,935	50 Added 416.67%	62 $22,000
Q1 2023 May 22, 2023	BUY	$246.13 - $285.47 $2,215 - $2,569	9 Added 300.0%	12 $3,000
Q1 2023 May 15, 2023	BUY	$246.13 - $285.47 $738 - $856	3 New	3 $1,000
Q2 2020 Aug 17, 2020	SELL	$144.67 - $207.03 $9,982 - $14,285	-69 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$126.5 - $225.1 $8,728 - $15,531	69 New	69 $13,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.